While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity. Market forces threaten the company's ability to serve all patients effectively ...

as the Affordable Insulin Now Act moves towards the US Senate. Shares in the UK's IP Group slid today after it said that an arthritis drug in development at portfolio company Istesso had failed a ...

Tariffs on foreign goods threaten the cost and quality of prescription medications – especially Chinese-made generics upon which the U.S. has become dependent.

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

Stories of prescriptions unfilled unite our urban and rural communities. The Save Local Pharmacies Act is about ensuring that ...

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

Most Americans (60%) would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research suggests. As a result, the majority of patients (63%) opt for ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...